US competition updates from the FTC regarding maximum penalty for violations, a limitation on future mergers and antitrust claims for the drug Daraprim, US competition litigation updates, and Mexico’s antitrust authority suspended several procedural deadlines
US competition updates from the FTC regarding maximum penalty for violations, a limitation on future mergers and antitrust claims for the drug Daraprim, US competition litigation updates, and Mexico’s antitrust authority suspended several procedural deadlines